Normal pregnancy is associated with profound alterations in the coagulation and fibrinolytic
systems. While these physiological procoagulant changes are aimed to minimise …

Haemostasis is a complex and dynamic equilibrium involving pro-coagulants, the natural
anticoagulation system and fibrinolysis. Normal human pregnancy is associated with …

Normal pregnancy is accompanied by changes in the coagulation and fibrinolytic systems.
These include increases in a number of clotting factors (I, II, VII, VIII, IX and XII), a decrease …

Pregnancy increases the risk of thrombosis four‐to five‐fold. Seventy‐five to eighty percent
of pregnancy‐related thrombotic events are venous and twenty to–twenty‐five percent are …

Normal pregnancy is accompanied by changes in the coagulation and fibrinolytic systems.
These include a decrease in platelet count, increases in a number of clotting factors, a …

In normal pregnancy, there is a marked increase in the procoagulant activity in maternal
blood characterized by elevation of factors VII, X, VIII, fibrinogen and von Willebrand factor …

Heritable coagulopathies are leading causes of maternal thromboembolism and are
associated with an increased risk of maternal and perinatal morbidity and mortality. The …

Pregnancy is a challenge to hemostasis. Guaranteeing sufficient passage of oxygen and
nutrients to the fetus as well as transportation of waste products from the fetus places great …

Both acquired and inherited thrombophilias are associated with an increased risk of
pregnancy‐related venous thromboembolism (VTE) as well as with adverse pregnancy …

The coagulation system undergoes significant change during pregnancy. The clinician
caring for the parturient must understand these changes, particularly when the parturient has …